SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cempra Pharmaceuticals, Inc. Announces Positive Top-Line Results From Solithromycin Phase 2 Clinical Trial in Patients With Uncomplicated Urogenital Gonorrhea